BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33411047)

  • 1. Assessment of an onco-sexology support and follow-up program in cervical or vaginal cancer patients undergoing brachytherapy.
    Kpoghomou MA; Geneau M; Menard J; Stiti M; Almont T; Ghose B; Attal J; Delannes M; Huyghe E; Ducassou A
    Support Care Cancer; 2021 Aug; 29(8):4311-4318. PubMed ID: 33411047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can an educational intervention improve compliance with vaginal dilator use in patients treated with radiation for a gynecological malignancy?
    Brand AH; Do V; Stenlake A
    Int J Gynecol Cancer; 2012 Jun; 22(5):897-904. PubMed ID: 22552831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative accounts of patients' determinants of vaginal dilator use after pelvic radiotherapy.
    Bakker RM; Vermeer WM; Creutzberg CL; Mens JW; Nout RA; Ter Kuile MM
    J Sex Med; 2015 Mar; 12(3):764-73. PubMed ID: 25424559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of vaginal pallor reaction in predicting late vaginal stenosis after high-dose-rate brachytherapy in treatment-naive patients with cervical cancer.
    Yoshida K; Yamazaki H; Nakamura S; Masui K; Kotsuma T; Akiyama H; Tanaka E; Yoshikawa N; Uesugi Y; Shimbo T; Narumi Y; Yoshioka Y
    J Gynecol Oncol; 2015 Jul; 26(3):179-84. PubMed ID: 25925294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.
    Martins J; Vaz AF; Grion RC; Costa-Paiva L; Baccaro LF
    BMC Cancer; 2021 Jun; 21(1):682. PubMed ID: 34112100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma.
    Bruner DW; Lanciano R; Keegan M; Corn B; Martin E; Hanks GE
    Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):825-30. PubMed ID: 8244811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.
    Kirchheiner K; Nout RA; Lindegaard JC; Haie-Meder C; Mahantshetty U; Segedin B; Jürgenliemk-Schulz IM; Hoskin PJ; Rai B; Dörr W; Kirisits C; Bentzen SM; Pötter R; Tanderup K;
    Radiother Oncol; 2016 Jan; 118(1):160-6. PubMed ID: 26780997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal dilator use to promote sexual wellbeing after radiotherapy in gynecological cancer survivors.
    Charatsi D; Vanakara P; Evaggelopoulou E; Simopoulou F; Korfias D; Daponte A; Kyrgias G; Tolia M
    Medicine (Baltimore); 2022 Jan; 101(4):e28705. PubMed ID: 35089231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative external beam irradiation with and without brachytherapy in pelvic node-positive IB1-IIA2 cervical cancer patients: a retrospective clinical study.
    Li L; Kou X; Feng X; Zhang M; Chao H; Wang L
    Radiat Oncol; 2015 Sep; 10():189. PubMed ID: 26377326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Template-based high-dose-rate interstitial brachytherapy in gynecologic cancers: a single institutional experience.
    Mahantshetty U; Shrivastava S; Kalyani N; Banerjee S; Engineer R; Chopra S
    Brachytherapy; 2014; 13(4):337-42. PubMed ID: 24176863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate normal tissue complication probability modeling of vaginal late toxicity after brachytherapy for cervical cancer.
    Annede P; Mailleux H; Sfumato P; Ferré M; Autret A; Varela Cagetti L; Macagno A; Fau P; Chargari C; Tallet A; Resbeut M; Zemmour C; Gonzague L; Boher JM
    Brachytherapy; 2018; 17(6):922-928. PubMed ID: 30061056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From "sex toy" to intrusive imposition: a qualitative examination of women's experiences with vaginal dilator use following treatment for gynecological cancer.
    Cullen K; Fergus K; Dasgupta T; Fitch M; Doyle C; Adams L
    J Sex Med; 2012 Apr; 9(4):1162-73. PubMed ID: 22304701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychoeducational group increases vaginal dilation for younger women and reduces sexual fears for women of all ages with gynecological carcinoma treated with radiotherapy.
    Robinson JW; Faris PD; Scott CB
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):497-506. PubMed ID: 10348277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDR brachytherapy for the reirradiation of cervical and vaginal cancer: analysis of efficacy and dosage delivered to organs at risk.
    Zolciak-Siwinska A; Bijok M; Jonska-Gmyrek J; Kawczynska M; Kepka L; Bujko K; Michalski W
    Gynecol Oncol; 2014 Jan; 132(1):93-7. PubMed ID: 24161366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy.
    Stahl JM; Qian JM; Tien CJ; Carlson DJ; Chen Z; Ratner ES; Park HS; Damast S
    Support Care Cancer; 2019 Apr; 27(4):1425-1433. PubMed ID: 30187220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose-rate intracavitary brachytherapy for cervical carcinomas with lower vaginal infiltration.
    Kazumoto T; Kato S; Tabushi K; Kutsutani-Nakamura Y; Mizuno H; Takahashi M; Shiromizu K; Saito Y
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1157-66. PubMed ID: 17459604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study.
    Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Westerveld H; Haie-Meder C; Petrič P; Mahantshetty U; Dörr W; Pötter R
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):88-95. PubMed ID: 24725693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
    Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
    Bingham B; Orton A; Boothe D; Stoddard G; Huang YJ; Gaffney DK; Poppe MM
    Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1040-1050. PubMed ID: 28332987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer.
    Mohamed S; Lindegaard JC; de Leeuw AA; Jürgenliemk-Schulz I; Kirchheiner K; Kirisits C; Pötter R; Tanderup K
    Radiother Oncol; 2016 Sep; 120(3):480-485. PubMed ID: 27267048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.